Three hospitals of QuirónSalud in Catalonia put in place units of DAO deficiency

The measurement of the functional activity of the enzyme DiaminoOxidasa consolidates its position as a key biomarker and after eight years since the beginning of the R&D project of DR Healthcare on the deficit of DAO as the principal cause of migraine and other associated symptoms, we are glad to see how it also consolidates at the clinical level. The Group Chiron Health has announced the implementation of units of Deficit of DAO in the entire network of hospitals that the group has in Spain.